NON-ALCOHOLIC FATTY LIVER DISEASE IN PEDIATRIC PATIENTS AFTER LIVER TRANSPLANTATION – A CASE REPORT

Thị Hương Thùy Bùi, Ngọc Thạch Hoàng , Thị Thúy Trần, Tuấn Khang Hoàng , Văn Đô Đỗ , Tùng Lâm Hoàng , Duy Hiền Phạm , Mạnh Hoàn Vũ, Thị Lan Vũ, Thị Thanh Hòa Nguyễn , Phạm Anh Hoa Nguyễn

Main Article Content

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease, cirrhosis, and hepatocellular carcinoma worldwide, with an estimated prevalence of 25%. The incidence of NAFLD post liver transplantation (LT) is on the rise. NAFLD is defined as the presence of fatty liver or non-alcoholic steatohepatitis (NASH) in patients undergoing LT for indications other than non-alcoholic steatohepatitis. We report a case of post-LT hepatic steatosis diagnosed, treated, and monitored at the National Children Hospital. The patient, an 18-month-old female, exhibited increased AST, ALT, and GGT levels after transplantation from day 29, an ultrasound showed diffuse hepatic echogenicity, and the diagnosis was confirmed by liver biopsy. The purpose of this article is to raise clinical awareness regarding NAFLD after LT

Article Details

References

1. Shetty A., Giron F., Divatia M.K., et al. (2021). Nonalcoholic Fatty Liver Disease after Liver Transplant. J Clin Transl Hepatol, 9(3), 428–435.
2. Kalogirou M.S. and Giouleme O. (2022). Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. World J Transplant, 12(9), 281–287.
3. Saeed N., Glass L., Sharma P., et al. (2019). Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis. Transplantation, 103(11), e345.